Table 5 Summary of multivariate analysis in all patients without neoadjuvant chemotherapy showing the odds ratio (95% confidence interval) of variables significantly associated with PD-L1 scoring methods and sTIL level

 ≥ 50 vs. < 50 years

0.50 (0.27, 0.92)^a

 White+Latino vs. Black

0.32 (0.14, 0.74)^b

0.21 (0.09, 0.53)^c

 Others vs. Black

NS

NS

 3 vs. 1 + 2

3.31 (1.38,7.93)^b

4.69 (2.57, 8.57)^c

 ≥ 10% vs. < 10%

3.48 (1.50, 8.11)^b

12.44 (6.59, 23.49)^c

23.12 (10.60, 50.42)^c

 ER/PR pos vs. TNBC

0.20 (0.10, 0.43)^c

 HER2 vs. TNBC

NS